Click on a filter below to refine your search. Remove a filter to broaden your search.
March 2020 to November 2022 saw a decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9%.
Adjusted hazard ratios for hospitalization and death were reduced with both treatments.
A review and meta-analysis show improvements in functional exercise capacity versus standard of care.
Those who survived COVID-19 had reduced mortality on days 181 to 365 and 366 to 730.
The Office of Long COVID Research and Practice will lead the US response to long COVID, which includes trials that already have been launched.